Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04453722 · ClinicalTrials.gov registry record
Prevention of Opioid-Induced Hypoxemia
A clinical trial of Noncardiac Surgery, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 49
- Enrollment target
- 1
- Study location
NCT04453722: Completed study of Noncardiac Surgery, sponsored by The Cleveland Clinic.
NCT04453722 is a study of Noncardiac Surgery that has completed, run by The Cleveland Clinic. The registered enrollment target is 49 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04453722, a study of Noncardiac Surgery, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the feasibility of a fully randomized validation trial for the Oxalert EPO.
Primary Outcome
Time-weighted average of SpO2 below a threshold of 90%. Oxygen Saturation measured between 0% - 100%. Oxygen Saturation \<90% is considered abnormal.
Conditions Studied
Interventions
- DEVICE Oxalert Monitor Mode
- DEVICE Oxalert Normal mode
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2020-06-26 |
| Est. Completion | 2023-06-15 |
What the finished NCT04453722 record still lists
NCT04453722 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 1 condition, with Noncardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Oxalert Monitor Mode is the first listed.
NCT04453722 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04453722 about?
NCT04453722 is a clinical study titled "Prevention of Opioid-Induced Hypoxemia". To evaluate the feasibility of a fully randomized validation trial for the Oxalert EPO.
What is the current status of trial NCT04453722?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2020-06-26. Estimated completion is 2023-06-15.
What conditions does trial NCT04453722 study?
This clinical trial studies the following conditions: Noncardiac Surgery.
What interventions are being tested in trial NCT04453722?
The interventions under investigation include: Oxalert Monitor Mode (DEVICE), Oxalert Normal mode (DEVICE).
Who is sponsoring clinical trial NCT04453722?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04453722 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Noncardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI